Skip to main content
State Seal State Seal State Seal
Home Button Home Button Home Button
 
 
 

Anita Somani News

Busy
Results 1 - 10 of 77
{"removedFilters":"","searchUpdateUrl":"\/members\/anita-somani\/news\/update-search","keywords":"","start":1,"pageSize":10,"sort":"PublishDateDesc"}
 
Sort Options
Sort Options
 
 

COLUMBUS – State Rep. Anita Somani (D-Dublin) today announced that the Ohio Controlling Board approved $1.8M in funding for the replacement of the four aging and failing boilers serving the entire Major General Robert Sprague Beightler Joint Force Headquarters Building. This building serves as the headquarters for the Adjutant General’s Department, a cabinet-level agency that manages the Ohio Army National Guard, Ohio Air National Guard, and State Defense Force.

Read Full Story
Fri, May 22, 2026

COLUMBUS – State Rep. Anita Somani (D-Dublin) today announced that the Ohio Controlling Board approved on Monday $30,450 to replace flooring at the Ohio School for the Deaf Recreation Center. The Ohio School for the Deaf Recreation Center, also known as the "Spartan Center" is the main connection hub for the school. The Spartan Center is used as a recreation area for residential students in the evenings as a community area, and it is also used during school hours for small events and as an alternate teaching space.  

Read Full Story
Fri, May 22, 2026

COLUMBUS – State Rep. Anita Somani (D-Dublin) today issued the following statement on the Pharmacy Board’s proposed rule to classify synthetic kratom as a Schedule 1 drug: 

Read Full Story
Mon, Apr 13, 2026

COLUMBUS — State Rep. Anita Somani (D-Dublin) today issued the following statement on House Bill (HB) 249, legislation that would ban drag shows outside of nightclubs and targets members of the LGBTQ+ community.

Read Full Story
Fri, Mar 27, 2026

COLUMBUS — State Rep. Anita Somani (D-Dublin) today issued the following statement on House Bill (HB) 347, legislation requiring a 24-hours waiting period for patients accessing reproductive care.

Read Full Story
Fri, Mar 27, 2026

COLUMBUS – State Rep. Anita Somani (D-Dublin) Monday announced that the Controlling Board approved $2.69M in funding for the renovation of the former elementary building of the Ohio School for the Deaf and the Ohio School for the Blind. This renovation will create a new administration space for the school and more pre-school classrooms to serve students. The Controlling Board also approved $96K to replace the HVAC system in the Deaf conference center at the school, which serves as a gathering space for the community.  

Read Full Story
Wed, Mar 18, 2026

COLUMBUS – State Reps. Ashley Bryant Bailey (D-Cincinnati) and Anita Somani (D-Dublin) Tuesday introduced their new bill, the Ohio Menopause and Hormone Therapy Act, also known as the Hormone Optimization Treatment Through Insurance Expansion (H.O.T.T.I.E.) Act. This bill would align Ohio's insurance standards with updated federal guidance and current clinical evidence regarding menopausal hormone therapy. It expands access to care and ensures patients can work with their doctors to make informed, individualized decisions about their health, without worrying about unaffordable out-of-pocket costs.

Read Full Story
Wed, Mar 18, 2026

COLUMBUS –State Rep. Anita Somani (D-Dublin) today released the following statement in response to Governor DeWine’s State of the State address.

Read Full Story
Tue, Mar 10, 2026

COLUMBUS — State Reps. Erika White (D-Springfield Township) and Anita Somani (D-Dublin) today announced they will be introducing legislation which would require the Governor’s approval before National Guard troops from other states can be stationed in Ohio, reinforcing state authority in deployment decisions.

Read Full Story
Tue, Feb 3, 2026

COLUMBUS — State Rep. Anita Somani (D-Dublin) today condemned a hearing held on January 14 by the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) on the abortion medication Mifepristone, which was cited as a “safety review.” Any medical professional with appropriate knowledge knows that the FDA has extensively researched the safety and efficacy of this medication.

Read Full Story
Fri, Jan 16, 2026